References
- Erowid. 2016. Erowid. https://www.erowid.org/experiences/exp.php?ID=8475 ( accessed June 8, 2016).
- AHFS. 2016. The American society of health-system pharmacists. http://www.ahfsdruginformation.com/loperamide ( accessed May 25, 2016).
- Anderson, L. 2016. Loperamide hydrochlorde. https://www.drugs.com/pro/loperamide.html ( accessed June 14, 2016).
- Baker, E. 2007. Loperamide: A pharmacological review. Reviews in Gastroenterological Disorders 7 (Suppl 3):S11–8.
- Baselt, C. 2008. Loperamide. In Disposition of toxic drugs and chemicals in man, ed. R. C. Baselt, 8th ed., 854–55. Foster City, CA: Biomedical Publications.
- Bertaccini, G. 2012. Mediators and drugs in gastrointestinal motility II: Endogenous and exogenous agents, 290. New York, NY: Springer Science & Business Media.
- Bluelight. 2016. Bluelight. http://www.bluelight.org/vb/threads/296086-Loperamide-(Immodium)-Megathread-We-have-now-lost-at-least-2-of-our-own-from-Lope/page21 ( accessed June 8, 2016).
- Crosier, B., and L. Marsch. 2016. Harnessing social media for substance use research and treatment. Journal of Alcoholism and Drug Dependence 4 (3). doi:10.4172/2329-6488.
- Daniulaityte, R., R. Carlson, and R. Falck. 2013. I just wanted to tell you that loperamide will work: A web-based study of extra-medical use of loperamide. Drug and Alcohol Dependence 130:241–44. doi:10.1016/j.drugalcdep.2012.11.003.
- Dierksen, J., M. Gonsoulin, and P. Walterscheid. 2015. Poor manʼs methadone. The American Journal of Forensic Medicine and Pathology 36 (4):268–70. doi:10.1097/PAF.0000000000000201.
- Eggleston, W., H. Clark, and J. Marraffa. 2016. Loperamide abuse associated with cardiac dysrhythmia and death. Annals of Emergency Medicine. doi:10.1016/j.annemergmed.2016.03.047.
- FAERS. 2016. FDA drug safety communication: FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse. http://www.fda.gov/Drugs/DrugSafety/ucm504617.htm ( accessed June 20, 2016).
- FDA. 2016. Loperamide hydrochloride. http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/017694s050lbl.pdf ( accessed June 20, 2016).
- Friedl, G., and A. Haenggeli. 1980. Loperamide overdose managed by naloxone. The Lancet 315:1413. doi:10.1016/S0140-6736(80)92674-4.
- Hanauer, S. 2008. The role of loperamide in gastrointestinal disorders. Reviews in Gastroenterological Disorders 8 (1):15–20.
- Heel, C., N. Brogden, and M. Speight. 1978. Loperamide: A review of its pharmacological properties and therapeutic efficacy in diarrhea. Drugs 15 (1):33–52. doi:10.2165/00003495-197815010-00003.
- Jaffe, J., M. Kanzler, and J. Green. 1980. Abuse potential of loperamide. Clinical Pharmacology and Therapeutics 28:6:812-819. doi:10.1038/clpt.1980.239.
- Litovitz, T., C. Clancy, and B. Korberly. 1997. Surveillance of loperamide ingestions: An analysis of 216 poison center reports. Journal of Toxicology: Clinical Toxicology 35 (1):11–19. doi:10.3109/15563659709001159.
- MacDonald, R., J. Heiner, and J. Villarreal. 2015. Loperamide dependence and abuse. BMJ Case Reports 2015. doi:10.1136/bcr-2015-209705.
- Marraffa, J., G. Holland, and W. Sullivan. 2014. Cardiac conduction disturbance after loperamide abuse. Clinical Toxicology 52 (9):952–57. doi:10.3109/15563650.2014.969371.
- Mukarram, O., Y. Hindi, and G. Catalasan. 2016. Loperamide induced torsades de pointes: A case report and review of the literature. Case Reports in Medicine 2016:1–3. doi:10.1155/2016/4061980.
- Nakamura, H., K. Ishii, and Y. Yokoyama. 1982. Physical dependence on loperamide hydrochloride in mice and rats. Yakugaku Zasshi 102 (11):1074–85.
- NIH. 2014. Using social media to better understand, prevent and treat substance use. https://www.nih.gov/news-events/news-releases/using-social-media-better-understand-prevent-treat-substance-use ( accessed June 2, 2016).
- Reddit. 2016. Reddit. https://www.reddit.com/r/Drugs/comments/z2k45/imodium_loperamide_for_opiate_withdrawals_tips/d ( accessed June 8, 2016).
- Sadeque, J., C. Wandel, and H. He. 2000. Increased drug delivery to the brain by P-glycoprotein inhibition. Clinical Pharmacology and Therapeutics 68 (3):231–37. doi:10.1067/mcp.2000.109156.
- Sarker, A., R. Ginn, and A. Nikfarjam. 2015. Using social media data for pharmacovigilance: A review. Journal of Biomedical Informatics 54:202–12. doi:10.1016/j.jbi.2015.02.004.
- Sobanski, P., M. Krajnik, and M. Shaqura. 2014. The presence of mu-, delta-, and kappa-opioid receptors in human heart tissue. Heart and Vessels 29 (6):855–63. doi:10.1007/s00380-013-0456-5.
- Tan-No, K., N. Nakagawasai, and T. Sato. 2003. Development of tolerance to the inhibitory effect of loperamide on gastrointestinal transit in mice. European Journal of Pharmaceutical Sciences 20 (3):357–63. doi:10.1016/j.ejps.2003.08.004.
- Upton, N. 2007. Cerebral uptake of drugs in humans. Clinical and Experimental Pharmacology & Physiology 34 (8):695–701. doi:10.1111/cep.2007.34.issue-8.
- Vandenbossche, J., M. Huisman, and Y. Xu. 2010. Loperamide and P-glycoprotein inhibition: Assessment of the clinical relevance. The Journal of Pharmacy and Pharmacology 62 (4):401–12. doi:10.1211/jpp.62.04.0001.
- Ward, J., C. Rosenbaum, and C. Hernon. 2011. Herbal medicines for the management of opioid addiction: Safe and effective alternatives to conventional pharmacotherapy? CNS Drugs 25:999–1007. doi:10.2165/11596830-000000000-00000.
- WHO. 2013. WHO model list of essential medicines. http://www.who.int/medicines/publications/essentialmedicines/en/index.html ( accessed June 2, 2016).
- Wightman, S., S. Hoffman, and A. Howland. 2016. Not your regular high: Cardiac dysrhythmias caused by loperamide. Clinical Toxicology 54 (5):454–58. doi:10.3109/15563650.2016.1159310.
- Yanagita, T., K. Miyasato, and J. Sato. 1979. Dependence potential of loperamide studied in rhesus monkeys. NIDA Research Monograph 27:106–13.